Several studies in recent years have shown that PHGDH inhibitors selectively block the growth of PHGDH-dependent cancer cells and that silencing the PHGDH gene significantly affects the development of PHGDH-dependent cancers, making the enzyme a new target for cancer therapy [10]. The gene discussed is PHGDH; the disease is cancer.